• Streptavidin-FITC for LNP Trafficking Assays

  2026-08-20

  Streptavidin-FITC enables biotin-resolved fluorescence for studying nanoparticle uptake, endosomal trafficking, and biomolecular localization. This article translates recent LNP trafficking findings into practical assay-design decisions, controls, and interpretation limits.

• Protease Inhibitor Cocktail: Workflow & Troubleshooting

  2026-08-19

  Learn how an EDTA-free, 100X formulation protects labile proteins, preserves phosphorylation-sensitive samples, and supports Western blot, immunoprecipitation, and enzyme workflows. Practical dilution guidance and troubleshooting steps help reduce degradation without compromising divalent-cation-dependent assays.

• DMXAA (Vadimezan): Mechanism and Research Use

  2026-08-19

  DMXAA, also called Vadimezan, is a preclinical vascular disrupting agent with reported DT-diaphorase inhibition, VEGFR2-related signaling effects, and tumor endothelial apoptosis. Its research value also extends to STING agonist delivery in a 2024 nanorod study, but that nanomedicine evidence should not be generalized to unconjugated DMXAA.

• Erlotinib and SCUBE3: A Translational EGFR Strategy

  2026-08-18

  Erlotinib offers a precise way to interrogate EGFR-dependent signaling while new SCUBE3 biology reframes tumor growth, therapy resistance, and immune suppression as interconnected processes. This thought-leadership guide translates that mechanism into practical assay design, biomarker strategy, and translational decision-making.

• BCECF for Extracellular pH Assays

  2026-08-18

  BCECF converts extracellular and accessible-compartment acid–base changes into a quantitative ratiometric signal, making it useful for ion transport, metabolism, and immune-cell microenvironment studies. This workflow-focused guide shows how to apply the probe to efferocytosis research while avoiding the common mistake of interpreting an extracellular pH signal as a direct intracellular pathway readout.

• ZNF263–ULK1 Autophagy in Cholangiocarcinoma

  2026-08-17

  This study identifies ZNF263 as an oncogenic transcription factor in intrahepatic cholangiocarcinoma and connects its activity to ULK1-dependent autophagy. By combining patient tissue analysis, functional assays, genome-wide binding and transcriptomic profiling, the authors show how ZNF263 supports ICC proliferation and nominate the ZNF263–ULK1 axis for further prognostic and mechanistic investigation.

• EZ Cap™ Firefly Luciferase mRNA Workflow

  2026-08-17

  Build sensitive, transient reporter assays around a Cap1-capped, polyadenylated mRNA that directly measures delivery and protein production. This guide connects practical luciferase workflows with redox-responsive peptide coacervates, while separating validated product specifications from assay-development recommendations.

• β-Elemene: AMPK Assays and Research Workflows

  2026-08-16

  β-Elemene provides a practical small-molecule tool for connecting adipocyte differentiation, insulin resistance, and AMPK signaling in a defined 3T3-L1 workflow. Its broader value extends to apoptosis, neuroprotection, inflammation, and analytical standardization, provided that solvent stability, dose tolerance, and pathway-specific controls are managed carefully.

• Biotin-XX Tyramide Reagent for Dynamic Surface Proteomics

  2026-08-15

  Biotin-XX Tyramide Reagent combines membrane-impermeant labeling with HRP-driven signal amplification for cell-surface and tissue assays. This article explains how its spatial chemistry can be matched to transient protein trafficking, using recent synaptic proximity-labeling research to guide experimental design.

• Leucomycin: From Biosynthesis to Assay Logic

  2026-08-14

  Leucomycin (kitasamycin) is more than a broad-spectrum macrolide: its biosynthetic history helps researchers interpret inhibition, resistance, and assay variability. This article connects classic pathway evidence with modern bacterial growth inhibition assay design.

• Protease Inhibitor Cocktail EDTA-Free Guide

  2026-08-14

  The Protease Inhibitor Cocktail EDTA-Free is a 100X DMSO formulation for broad-spectrum protection of proteins during extraction and analysis. Its EDTA-free design supports cation-sensitive workflows, including phosphorylation analysis, Western blotting, and co-immunoprecipitation, when used at the documented dilution.

• JZL184 Workflow for MAGL and Pain Research

  2026-08-13

  JZL184 provides a targeted way to increase 2-arachidonoylglycerol signaling while connecting synaptic, inflammatory pain, and affective-behavior assays. This practical guide translates recent cannabidiol pain research into controlled MAGL-inhibition workflows, with formulation, endpoint selection, and troubleshooting strategies for reproducible experiments.

• U0126-EtOH: MEK1/2 Inhibition Workflows

  2026-08-13

  U0126-EtOH is a selective MEK1/2 inhibitor for mapping MAPK/ERK signaling in neuronal injury, oxidative stress, inflammation, and mechanistic cancer assays. This guide connects pathway inhibition to practical dosing, phospho-ERK readouts, assay controls, and troubleshooting decisions.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus Guide

  2026-08-12

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus combines T7 transcription, ARCA capping, and poly(A)-tail design in a workflow suited to translation-ready RNA. This guide connects practical reaction setup and troubleshooting with mRNA nanovaccine development, in vitro translation, RNAi, and structure-function studies.

• Vitamin C, ROS/NF-κB, and Cochlear Senescence

  2026-08-12

  A 2024 Molecular Biology Reports study shows that vitamin C ameliorates D-galactose-induced senescence in HEI-OC1 cochlear hair cells, with protective effects associated with reduced ROS accumulation and NF-κB activation. The findings position the ROS/NF-κB axis as a mechanistically testable link between oxidative stress, inflammatory signaling, and cellular aging relevant to age-related hearing loss research.

546 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page